{"schema_version":"secwatch.filing_event.v1","accession":"0000849146-22-000078","form_type":"8-K","ticker":"LFVN","cik":"0000849146","company_name":"Lifevantage Corp","filed_at":"2022-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.714433+00:00","generated_at":"2026-06-22T16:16:18.656017+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LifeVantage Q1 revenue $51.8M (-2.7% YoY); adj. EPS $0.06 vs $0.23; dividend $0.03","bullets":["Revenue $51.8M, down 2.7% YoY; constant-currency revenue up 2.3%.","Net income $0.6M ($0.05 diluted EPS) vs $3.3M ($0.25) a year ago.","Adjusted EBITDA $2.8M vs $5.8M; active accounts declined 6.7% to 153,000.","Declared $0.03/share cash dividend payable Dec 15, 2022 to holders of record Dec 1.","FY2023 guidance: revenue $200M-$212M, adj. EBITDA $12M-$14M, adj. EPS $0.27-$0.39."],"urls":{"canonical":"https://secwatch.observer/filing/0000849146-22-000078","json":"https://secwatch.observer/filing/0000849146-22-000078.json","markdown":"https://secwatch.observer/filing/0000849146-22-000078.md","text":"https://secwatch.observer/filing/0000849146-22-000078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/849146/000084914622000078/0000849146-22-000078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/849146/000084914622000078/lfvn-20221102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T16:16:18.656017+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"210f87592a89906f96a77d20e290e27a2b3bcbd6","claim":"Lifevantage Corp reported the first fiscal quarter ended September 30, 2022 results: revenue $51.8 million, net income $0.6 million, or $0.05 per diluted share, EPS $0.05 per diluted share. Guidance reaffirmed.","evidence_excerpt":"LifeVantage Corporation (Nas daq: LFVN) today reported financial results for its first fiscal quarter ended September 30, 2022. First Quarter Fiscal 2023 Summary*: • Revenue of $51.8 million, a decrease of 2.7% from the prior year period. Excluding the negative impact of foreign currency fluctuations, first quarter revenue was up approximately 2.3%; • Revenue in the","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/849146/000084914622000078/0000849146-22-000078-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first fiscal quarter ended September 30, 2022"},{"label":"Revenue","value":"$51.8 million"},{"label":"Net income","value":"$0.6 million, or $0.05 per diluted share"},{"label":"EPS","value":"$0.05 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"85237146ea79ddaac80edcb515926da5f2a863cb","claim":"Lifevantage Corp reported fiscal year 2023 results: revenue range of $200 million to $212 million, EPS range of $0.27 to $0.39. Guidance reaffirmed.","evidence_excerpt":"2022 to all stockholders of record at the close of business on December 1, 2022. Fiscal Year 2023 Guidance The Company continues to expect to generate revenue in the range of $200 million to $212 million in fiscal year 2023 and adjusted EBITDA of $12 million to $14 million, with adjusted earnings per share in the range of $0.27 to $0.39, which assumes a full year","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/849146/000084914622000078/0000849146-22-000078-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year 2023"},{"label":"Revenue","value":"range of $200 million to $212 million"},{"label":"EPS","value":"range of $0.27 to $0.39"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}